Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04908956 |
| Consolidated Lead Sponsor | ETOP IBCSG Partners Foundation |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 6 participants (ACTUAL) |
| Registered Start Date | 2022-08-04 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Leiden University Medical Center | Leiden, Netherlands | Open Hospital Dossier -> |
| National University Hospital | Singapore, Singapore | Open Hospital Dossier -> |
| National Cancer Center | Goyang-si, South Korea | Open Hospital Dossier -> |
| Sahlgrenska University hospital | Gothenburg, Sweden | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.